DISCOVER
MOLECULAR INTERACTIONS
dynamicBIOSENSORS WEBINAR SERIES I NEXT DATE: JUNE 12, 2024
Find the right assay for your research project.
The DISCOVER MOLECULAR INTERACTIONS webinar series is designed to help you find the right assay for your research project!
Each month we will talk about cutting-edge drug discovery topics like bispecific antibodies, PROTACs or RNA-binding small molecules.
We will show you how to characterize the respective molecular interactions in depth, how to create assays with remarkable biological similarity, low sample consumption, high versatility and exceptional ease-of-use.
You are a switchSENSE® or RT-IC user and want to learn more about specific applications?
You use a different technology like SPR and are curious about alternatives?
You do not use a biophysical technology and want to learn more about how to advance your research project with kinetic measurements?
We’ve got you covered!
Explore our webinar topics below and register today:
DISCOVER molecular interactions. TOGETHER.
August 2024
There will be no webinar episode in August. Instead, we invite you to join us at our yearly User Meeting taking place in Munich, Sep 11-13. Meet experts from academia and industry who will be sharing their work using switchSENSE® and RT-IC technologies.
→FIND MORE INFORMATION, THE AGENDA AND THE REGISTRATION FORM HERE
DISCOVER reverse transcriptase activity: catalytic rates of nucleic acid-modifying enzymes
September 18, 2024 | 5 PM (CEST)
In this episode, Eva Hoffmann from the University of Cologne is showcasing a very unique application of the switchSENSE® technology: the real-time measurement of catalytic rates of nucleic acid modifying enzymes. She investigated the reverse transcription of unnatural base pairs with a series of assays to determine the retention of unnatural base pairs in RNA in vitro evolution.
DISCOVER bispecific antibodies: generation, biophysical characterization and functional validation
October 9, 2024 | 5 PM (CEST)
The affinity of therapeutic antibodies is a critical parameter in drug discovery, as optimizing it can improve their efficacy and thus limit adverse effects and costs of the treatment. In this episode, Prof. Harald Kolmar from the Technical University of Darmstadt will talk about new advances in the field of antibody engineering, specifically the design and affinity maturation of bispecific antibodies. A bispecific antibody targeting EGFR and PD-L1 is investigated using different biophysical technologies in order to test whether the affinity for EGFR can be optimized without negatively affecting PD-L1 binding.
DISCOVER more applications and topics:
You can find recordings of all our previous webinar episodes in our →YouTube webinar playlist.